Cached score snapshot

US.ZBH · Zimmer Biomet

110分制 60.5/110;5D動能v2 19/50;排序分 79.5/160

Ranking score 79.5/160
Main score 60.5/110
5D momentum v2 19/50
Rank #48
Setup grade D 42.1

Score breakdown

觀望

Medium twelvedata

Score and price trend

D 42.1 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 03-30 07-02 07-15 07-27 08-05 $76.72$94.14$111.56 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.872 · anchors 120 -0.40% -2.47% / +1.64% 45.2% 8.2% Actual +0.75% · vs median +1.15% · inside 25-75 band
30D observation +2.85% -3.41% / +9.34% 61.8% 18.6% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 -0.17% -2.01% / +2.35% 45.6% 6.9% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-03-30 → 2026-08-05 · 481 archived points · 2 Improving turn signal · 5 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 79.5
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 60.5/110 (觀望)
5D momentum v2 19/50 (弱)
Score with momentum v2 79.5/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 86.606
ma50 86.723
close 90.56
prevClose 87.57
avgVolume20 2238002
volumeRatio 0.92
changePercent 3.41

Metrics snapshot

close 90.56
volume 2048437
changePercent 3.41

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 60.5/110
Main rating 觀望
5D momentum v2 19/50
Score with momentum v2 79.5/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.5/5 · 較差

Dimension score 2.5/5
Dimension grade 較差

Sub-items

pbPoints 0.5
pePoints 0.4
epsPoints 0
roePoints 0
debtPoints 0.4
marginPoints 0
turnoverUsdM 185.5065
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.4

資金流 — 13.2/20 · 一般

Dimension score 13.2/20
Dimension grade 一般

Sub-items

cmfPoints 0.8
mfiPoints 4
obvPoints 2.4
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.ZBH
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 11.6/15 · 良好

Dimension score 11.6/15
Dimension grade 良好

Sub-items

vix

score 1.8

details

source twelvedata+fred
vixClose 19.49

trend

score 2.8

details

qqq

ma20 726.87
ma50 699.6554
name QQQ
close 710.62
points 1.4

spy

ma20 745.6905
ma50 732.9736
name SPY
close 733.24
points 1.4
source twelvedata+fred
atrPct 2.4388
atrPoints 3
cciPoints 4
vixPoints 1.8
marketTrendPoints 2.8

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 7
catalystCount 0
catalystPoints 2

風險管理 — 7.4/10 · 良好

Dimension score 7.4/10
Dimension grade 良好

Sub-items

position

score 1.4

details

atrPct 2.4388
turnoverUsdM 185.5065
liquidityPoints 0.4
volatilityPoints 1
rrPoints 1.6

stopLevels

symbol US.ZBH
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 86.1428

strength_details

ma_score 1
atr_score 2
rsi_score 3
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1.5
stop_loss_percent 4.9
take_profit_price 97.2005
target_multiplier 2.2
technical_strength 2.05
take_profit_percent 7.3
positionPoints 1.4
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.4966
stopLossPercent 4.8777
diversificationPoints 2

技術信號 — 21.8/30 · 良好

Dimension score 21.8/30
Dimension grade 良好

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 3.2
macdPoints 4

vcpPayload

vcp_pass true
vcp_score 3.2
vcp_reason 波幅收縮(12.6%→5%);跌縮量(近10日3日);站上MA50;升放量(近10日2日);收盤突破20日高位;Ready=Y;Confirm=Y

vcp_metrics

up_days 4
vol_ref 2264506.6667
down_days 5
vcp_ready true
above_ma50 true
avg_vol_10 2302850
avg_vol_20 2239215
avg_vol_30 2264506.6667
range_pct_10 0.0496
range_pct_20 0.0985
range_pct_30 0.1257
up_expand_ok true
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok true
up_expand_days 2
breakout_20d_ok true
vol_ratio_10_30 1.0169
dist_to_20d_high -0.0007
down_shrink_days 3
breakout_level_20d 90.5
vcp_breakout_confirm true
contraction_ratio_10_30 0.3946
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.8
rsiKdjPoints 3.2
volumeWeight 2
maCrossPoints 0
shortRsiPoints 1
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 0.8

情緒分析 — 2/10 · 較差

Dimension score 2/10
Dimension grade 較差

Sub-items

sentiment

score 2

details

source finnhub_news_keyword_model
articleCount 7
negativeHits 2
positiveHits 2
sentimentScoreRaw 0

sentimentData

raw {"id":140715814,"url":"https://finnhub.io/api/news?id=36eb28a8270750c86ed8bc23e2ca5708f0ab83df06a973b054459d97cfe0c8fd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.","category":"company","datetime":1782314640,"headline":"ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?"}, {"id":140602225,"url":"https://finnhub.io/api/news?id=9fe49e482bc56bb05f6d592cd872efd951762204c6033e9b9fab15984cbee012","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Zimmer Biomet Holdings currently sits with no changes to its published price targets, so you are working with the same reference points that were already in place. With no fresh analyst commentary on record, recent market moves are not being framed by new Wall Street narratives. Read on to see how you can track future revisions and keep up with how the story around this stock evolves over time. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to...","category":"company","datetime":1781137165,"headline":"Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst Updates"}, {"id":140581614,"url":"https://finnhub.io/api/news?id=e807ea147c809c9a05caecce5563b33b2635da17565f7f169c1e40b8dcce745a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Is ZBH a good stock to buy? We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.’s share was trading at $87.27 as of June 8th. ZBH’s trailing and forward P/E were 22.62 and 10.46 respectively according […]","category":"company","datetime":1781015440,"headline":"Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?"}, {"id":140573692,"url":"https://finnhub.io/api/news?id=3c731df515e487f63c0aeca355fc5c45231f7a5fdfaa49df13f31c359af95d84","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"ZBH","summary":"Zimmer Biomet Holdings, Inc. (ZBH) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 10:40 AM EDTCompany ParticipantsIvan Tornos -...","category":"company","datetime":1780938510,"headline":"Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"}, {"id":140447049,"url":"https://finnhub.io/api/news?id=68e783a1f7d7f1c5f76f949885719c7d67d503b03ffbb9896ce38fb811ebf383","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1779982221,"headline":"Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue?"}, {"id":140435001,"url":"https://finnhub.io/api/news?id=8da8881f1410a134869809e6e5294d0385017ddf3b1d73f443ab41aecd5fc04d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Over the past six months, Zimmer Biomet’s shares (currently trading at $85.45) have posted a disappointing 12.4% loss, well below the S&P 500’s 9.1% gain. This might have investors contemplating their next move.","category":"company","datetime":1779897204,"headline":"3 Reasons to Sell ZBH and 1 Stock to Buy Instead"}, {"id":140420479,"url":"https://finnhub.io/api/news?id=b70082c170e45eb4b50cc25e05c10dae5407ada933d6c97f101e23b60dd0374d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to $83 from $93 on April 29, and maintained a Buy rating on the shares. The firm stated that the company delivered a solid fiscal Q1 to start the year, […]","category":"company","datetime":1779797341,"headline":"Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?"}
raw_source {"id":140715814,"url":"https://finnhub.io/api/news?id=36eb28a8270750c86ed8bc23e2ca5708f0ab83df06a973b054459d97cfe0c8fd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.","category":"company","datetime":1782314640,"headline":"ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?"}, {"id":140705492,"url":"https://finnhub.io/api/news?id=1374c0428d1b2f30e94c855825a137bd852b3b4e88be883228e4e073a0ee8595","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"While the market fixates on a disruptive quarter for Stryker stock, the company's powerful ability to convert profit into hard cash reveals a deeper, under-appreciated resilience.","category":"company","datetime":1782238309,"headline":"The Cash-Flow Fortress The Stryker Stock Bears Keep Missing"}, {"id":140671540,"url":"https://finnhub.io/api/news?id=b85f73c9839ef1c88922e1e344a59e1c8b958316f1c6760961e5524a9583e6e1","image":"https://image.cnbcfm.com/api/v1/image/108323633-5ED3-MM-E-BLOCK-061726.jpg?v=1781738910&w=1920&h=1080","source":"CNBC","related":"ZBH","summary":"'Mad Money' host Jim Cramer weighs in on stocks including: Fair Isaac Corporation, Clover Health, Vistra, and Stryker Corporation.","category":"company","datetime":1781726833,"headline":"Lightning Round: I like FICO but I am afraid it's going to be hurt by AI, says Jim Cramer"}, {"id":140643627,"url":"https://finnhub.io/api/news?id=1cf6cf264296e34cf6aa6b883260c6b94b4448c6df4d5586d01127206df8dadb","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2210914563/image_2210914563.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ZBH","summary":"Zimmer Biomet (ZBH) looks undervalued: strong free cash flow, high margins, sales/EPS growth, buybacks and manageable debt. See more details here.","category":"company","datetime":1781581929,"headline":"Zimmer Biomet: Does Slow And Steady Still Win The Race?"}, {"id":140638992,"url":"https://finnhub.io/api/news?id=55c6e6735b3614e92e560eaa15ab79337321693464dc85a5555a3aab2a2c0302","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Zimmer Biomet has lagged the broader S&P 500 Index over the past year, and analysts remain on the sidelines as they weigh the company's steady fundamentals against its modest growth outlook.","category":"company","datetime":1781524151,"headline":"Is Zimmer Biomet Stock Underperforming the S&P 500?"}, {"id":140613133,"url":"https://finnhub.io/api/news?id=fa7dc8445299911bf16502caaeab45d89c5c4cbbc69b958e2ee1a72a63a007d6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Is SOLV a good stock to buy? We came across a bullish thesis on Solventum Corporation on r/ValueInvesting by raytoei. In this article, we will summarize the bulls’ thesis on SOLV. Solventum Corporation’s share was trading at $82.46 as of June 9th. SOLV’s trailing and forward P/E were 10.09 and 12.58 respectively according to Yahoo Finance. Solventum […]","category":"company","datetime":1781208796,"headline":"Is Solventum Corporation (SOLV) A Good Stock To Buy Now?"}, {"id":140602225,"url":"https://finnhub.io/api/news?id=9fe49e482bc56bb05f6d592cd872efd951762204c6033e9b9fab15984cbee012","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Zimmer Biomet Holdings currently sits with no changes to its published price targets, so you are working with the same reference points that were already in place. With no fresh analyst commentary on record, recent market moves are not being framed by new Wall Street narratives. Read on to see how you can track future revisions and keep up with how the story around this stock evolves over time. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to...","category":"company","datetime":1781137165,"headline":"Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst Updates"}, {"id":140581614,"url":"https://finnhub.io/api/news?id=e807ea147c809c9a05caecce5563b33b2635da17565f7f169c1e40b8dcce745a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Is ZBH a good stock to buy? We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.’s share was trading at $87.27 as of June 8th. ZBH’s trailing and forward P/E were 22.62 and 10.46 respectively according […]","category":"company","datetime":1781015440,"headline":"Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?"}, {"id":140581511,"url":"https://finnhub.io/api/news?id=46db3f2ddb8f68a9fda811f499351527e0ebbe2252337876f92aa9582fde5c35","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"ISRG lifts margins despite tariffs, using scale, cost cuts and da Vinci 5 adoption to offset inflation as 2026 cost pressures build.","category":"company","datetime":1781014020,"headline":"Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?"}, {"id":140581528,"url":"https://finnhub.io/api/news?id=fff801fa2f8f5420353b512baf5d61c8d4ac7e0cb77437df58f4af361c100815","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Globus Medical is riding on musculoskeletal market growth with strong Q1 sales gains, double-digit spine growth, and rising trauma demand across key product lines.","category":"company","datetime":1781013660,"headline":"Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom"}, {"id":140573692,"url":"https://finnhub.io/api/news?id=3c731df515e487f63c0aeca355fc5c45231f7a5fdfaa49df13f31c359af95d84","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"ZBH","summary":"Zimmer Biomet Holdings, Inc. (ZBH) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 10:40 AM EDTCompany ParticipantsIvan Tornos -...","category":"company","datetime":1780938510,"headline":"Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"}, {"id":140538765,"url":"https://finnhub.io/api/news?id=154616564cbf3982765e3e6bd14f79360db48ccb79cfcda02804e9f0b4f1bb48","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1780673427,"headline":"Why Is Perrigo (PRGO) Down 9% Since Last Earnings Report?"}, {"id":140525761,"url":"https://finnhub.io/api/news?id=208a7fca9c2fb19fe671ca5b45ad12cb4688fe71c05248efbdeab44509fdb3a9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Globus Medical's debt-free balance sheet, nearly $630M in liquid assets and strong cash flow give it the flexibility to fund growth and support shareholders.","category":"company","datetime":1780588500,"headline":"Here's How Financial Strength Remains a Key Advantage for GMED"}, {"id":140500624,"url":"https://finnhub.io/api/news?id=a5e65034a45c9049f09c1511bc42d5210be3019312b0c99d59a2ee7bb47837e4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Globus Medical is riding musculoskeletal market growth with spine, trauma and ortho gains, strong cash flow and a debt-free balance sheet.","category":"company","datetime":1780410540,"headline":"Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?"}, {"id":140498523,"url":"https://finnhub.io/api/news?id=dc236427ceaf3d1a5e737ff55f7ddacae7bc6aff8b01ca6eaba9f9f8db94bfe7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8 with a fireside chat at 10:40 a.m. ET.","category":"company","datetime":1780399800,"headline":"Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference"}, {"id":140497868,"url":"https://finnhub.io/api/news?id=1e939934e2e5739e9e6c8226ea4e4c29629eca8fb63f3fdd9c03c88d0f1eec9e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.","category":"company","datetime":1780394243,"headline":"2 Profitable Stocks to Consider Right Now and 1 We Question"}, {"id":140460516,"url":"https://finnhub.io/api/news?id=8087e2bad148885b17ab7dc0369a07e9077ba8fa101ee49c0398193adc357cd4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"GE HealthCare (GEHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1780068606,"headline":"GE HealthCare (GEHC) Up 3.3% Since Last Earnings Report: Can It Continue?"}, {"id":140451402,"url":"https://finnhub.io/api/news?id=4d4b45bd859b29d0ba102e343cd5e3952515a884bb0f1e3a10f69952228c51fc","image":"","source":"Benzinga","related":"ZBH","summary":"Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and lowers the price target from $95 to $93.","category":"company","datetime":1779984634,"headline":"Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $93"}, {"id":140447049,"url":"https://finnhub.io/api/news?id=68e783a1f7d7f1c5f76f949885719c7d67d503b03ffbb9896ce38fb811ebf383","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1779982221,"headline":"Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue?"}, {"id":140443709,"url":"https://finnhub.io/api/news?id=537fbfb375ad4f7d8910fee5a75b0417b01bb38fbd04ce57abd40c92ecf5833b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destocking have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 1.2% has lagged the S&P 500’s 9.8% climb.","category":"company","datetime":1779974307,"headline":"3 Healthcare Stocks That Fall Short"}, {"id":140435000,"url":"https://finnhub.io/api/news?id=acc8a51efa459f1e33a2c33e16a16fb62d5c2d9bd360fe0b82bfab958ec4a472","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announces that its TMINI® Miniature Robotic System has been used in its 5,000th total knee (TKA) procedure. The 5,000th case was recently completed by Dr. John Tiberi of Cedars-Sinai Orthopedics in Los Angeles, CA.","category":"company","datetime":1779897600,"headline":"THINK Surgical Announces the TMINI® Miniature Robotic System 5,000th Procedure Milestone"}, {"id":140435001,"url":"https://finnhub.io/api/news?id=8da8881f1410a134869809e6e5294d0385017ddf3b1d73f443ab41aecd5fc04d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Over the past six months, Zimmer Biomet’s shares (currently trading at $85.45) have posted a disappointing 12.4% loss, well below the S&P 500’s 9.1% gain. This might have investors contemplating their next move.","category":"company","datetime":1779897204,"headline":"3 Reasons to Sell ZBH and 1 Stock to Buy Instead"}, {"id":140420479,"url":"https://finnhub.io/api/news?id=b70082c170e45eb4b50cc25e05c10dae5407ada933d6c97f101e23b60dd0374d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ZBH","summary":"Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to $83 from $93 on April 29, and maintained a Buy rating on the shares. The firm stated that the company delivered a solid fiscal Q1 to start the year, […]","category":"company","datetime":1779797341,"headline":"Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?"}
data_source finnhub_news_keyword_model
article_count 7
negative_hits 2
positive_hits 2
recomputed_at_score true
sentiment_score_raw 0
source_article_count 23
discarded_article_count 16
sentimentPoints 2

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 2.5 5/110 50% 2.5
資金流 13.2 20/110 66% 13.2
市場環境 11.6 15/110 77.33% 11.6
催化劑 2 20/110 10% 2
風險管理 7.4 10/110 74% 7.4
技術信號 21.8 30/110 72.67% 21.8
情緒分析 2 10/110 20% 2

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 19/50
ret_5d 0.0138
max_score 50
max_total 50
raw_total 19
vcp_bonus 2
vol_ratio 0.9148
ret_points 4
vol_points 0
range_ratio 1.1739
volat_points 0
day_range_pct 0.0283
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 8
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d true
return_window_days 5
first_breakout_bonus 2
breakout_quality_points 2

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.4

details

atrPct 2.4388
turnoverUsdM 185.5065
liquidityPoints 0.4
volatilityPoints 1
rrPoints 1.6

stopLevels

symbol US.ZBH
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 86.1428

strength_details

ma_score 1
atr_score 2
rsi_score 3
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1.5
stop_loss_percent 4.9
take_profit_price 97.2005
target_multiplier 2.2
technical_strength 2.05
take_profit_percent 7.3
positionPoints 1.4
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.4966
stopLossPercent 4.8777
diversificationPoints 2

Calculation audit log

基本面分析總分: 2.5/5分
資金流分析總分: 13.2/20分
市場環境分析總分: 11.6/15分
催化劑分析: 2/20分
風險管理總分: 7.4/10分
技術信號分析總分: 21.8/30分
情緒分析: 2/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 2.2086
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.44
cci
rule Cursor_18.24 CCI bands
level 強勢區
score 10
value 99.05
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.0459
kdj
d 53.64
j 72.74
k 60.01
rule Cursor_18.24 K/D cross
score 6
signal 強金叉
mfi
rule Cursor_18.24 MFI bands
level 強資金流入
score 10
value 73.78
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 6
trend 有流入
value 12774337
recentSlope 501783.7
previousSlope 776850
rsi
value 66.03
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 86.8267
position SAR喺價下
distancePct 4.12
previousTrend 上升
ma50
value 86.723
macd
macd 0.8605
trend 強烈看漲
signal 0.5972
histogram 0.2634
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 86.5344
position 連續5日>VWAP
consecutiveAbove 16
volume
rule Cursor_18.24 volume ratio
level 無力
ratio 0.92
score 4
avgVolume 2238002
currentVolume 2048437
derived
ma20 86.606
ma50 86.723
prevClose 87.57
avgVolume10 2320714
avgVolume20 2238002
changePercent 3.41
avgVolumeForScore 2238002
ma_cross
ma20 86.606
ma50 86.723
rule Cursor_18.24 MA20/MA50 cross
cross 熊勢
score 0
prevMa20 86.2985
prevMa50 86.8186
spreadPct 0.13
isVolumeBreakout false
bollinger
lower 81.7264
upper 91.4856
position 上半部
rsi_short
value 63.69
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.92

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.4388250883392226,
        "turnoverUsdM": 185.50645472,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.6,
    "stopLevels": {
      "symbol": "US.ZBH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 86.1428,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.5,
      "stop_loss_percent": 4.9,
      "take_profit_price": 97.2005,
      "target_multiplier": 2.2,
      "technical_strength": 2.05,
      "take_profit_percent": 7.3
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.4966222946663044,
    "stopLossPercent": 4.877650176678445,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 79.5,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 60.5,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 19
  },
  "market": {
    "ma20": 86.606,
    "ma50": 86.723,
    "close": 90.56,
    "prevClose": 87.57,
    "avgVolume20": 2238002,
    "volumeRatio": 0.92,
    "changePercent": 3.41
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 19,
    "details": {
      "ret_5d": 0.013769170491436222,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 19,
      "vcp_bonus": 2,
      "vol_ratio": 0.9148013924522657,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 1.1739234081649106,
      "volat_points": 0,
      "day_range_pct": 0.028268584363957537,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 8,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": true,
      "return_window_days": 5,
      "first_breakout_bonus": 2,
      "breakout_quality_points": 2
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 79.5,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 50,
        "contribution": 2.5
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 11.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 77.33,
        "contribution": 11.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 21.8,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 72.67,
        "contribution": 21.8
      },
      {
        "raw": 2,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 20,
        "contribution": 2
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 60.5,
    "details": [
      "基本面分析總分: 2.5/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 11.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 21.8/30分",
      "情緒分析: 2/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.5,
      "資金流": 13.2,
      "市場環境": 11.6,
      "情緒分析": 2,
      "技術信號": 21.8,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.4,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 185.50645472,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 4,
          "obvPoints": 2.4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.ZBH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "良好",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 19.49
            }
          },
          "trend": {
            "score": 2.8,
            "details": {
              "qqq": {
                "ma20": 726.8700022500002,
                "ma50": 699.6553995000002,
                "name": "QQQ",
                "close": 710.62,
                "points": 1.4
              },
              "spy": {
                "ma20": 745.6905002499999,
                "ma50": 732.9736006400001,
                "name": "SPY",
                "close": 733.23999,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.4388250883392226,
          "atrPoints": 3,
          "cciPoints": 4,
          "vixPoints": 1.8,
          "marketTrendPoints": 2.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "negativeHits": 2,
              "positiveHits": 2,
              "sentimentScoreRaw": 0
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140715814,
                "url": "https://finnhub.io/api/news?id=36eb28a8270750c86ed8bc23e2ca5708f0ab83df06a973b054459d97cfe0c8fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.",
                "category": "company",
                "datetime": 1782314640,
                "headline": "ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?"
              },
              {
                "id": 140602225,
                "url": "https://finnhub.io/api/news?id=9fe49e482bc56bb05f6d592cd872efd951762204c6033e9b9fab15984cbee012",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings currently sits with no changes to its published price targets, so you are working with the same reference points that were already in place. With no fresh analyst commentary on record, recent market moves are not being framed by new Wall Street narratives. Read on to see how you can track future revisions and keep up with how the story around this stock evolves over time. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to...",
                "category": "company",
                "datetime": 1781137165,
                "headline": "Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst Updates"
              },
              {
                "id": 140581614,
                "url": "https://finnhub.io/api/news?id=e807ea147c809c9a05caecce5563b33b2635da17565f7f169c1e40b8dcce745a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Is ZBH a good stock to buy? We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.’s share was trading at $87.27 as of June 8th. ZBH’s trailing and forward P/E were 22.62 and 10.46 respectively according […]",
                "category": "company",
                "datetime": 1781015440,
                "headline": "Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?"
              },
              {
                "id": 140573692,
                "url": "https://finnhub.io/api/news?id=3c731df515e487f63c0aeca355fc5c45231f7a5fdfaa49df13f31c359af95d84",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings, Inc. (ZBH) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 10:40 AM EDTCompany ParticipantsIvan Tornos -...",
                "category": "company",
                "datetime": 1780938510,
                "headline": "Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"
              },
              {
                "id": 140447049,
                "url": "https://finnhub.io/api/news?id=68e783a1f7d7f1c5f76f949885719c7d67d503b03ffbb9896ce38fb811ebf383",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1779982221,
                "headline": "Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 140435001,
                "url": "https://finnhub.io/api/news?id=8da8881f1410a134869809e6e5294d0385017ddf3b1d73f443ab41aecd5fc04d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Over the past six months, Zimmer Biomet’s shares (currently trading at $85.45) have posted a disappointing 12.4% loss, well below the S&P 500’s 9.1% gain. This might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1779897204,
                "headline": "3 Reasons to Sell ZBH and 1 Stock to Buy Instead"
              },
              {
                "id": 140420479,
                "url": "https://finnhub.io/api/news?id=b70082c170e45eb4b50cc25e05c10dae5407ada933d6c97f101e23b60dd0374d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to $83 from $93 on April 29, and maintained a Buy rating on the shares. The firm stated that the company delivered a solid fiscal Q1 to start the year, […]",
                "category": "company",
                "datetime": 1779797341,
                "headline": "Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?"
              }
            ],
            "raw_source": [
              {
                "id": 140715814,
                "url": "https://finnhub.io/api/news?id=36eb28a8270750c86ed8bc23e2ca5708f0ab83df06a973b054459d97cfe0c8fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.",
                "category": "company",
                "datetime": 1782314640,
                "headline": "ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?"
              },
              {
                "id": 140705492,
                "url": "https://finnhub.io/api/news?id=1374c0428d1b2f30e94c855825a137bd852b3b4e88be883228e4e073a0ee8595",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "While the market fixates on a disruptive quarter for Stryker stock, the company's powerful ability to convert profit into hard cash reveals a deeper, under-appreciated resilience.",
                "category": "company",
                "datetime": 1782238309,
                "headline": "The Cash-Flow Fortress The Stryker Stock Bears Keep Missing"
              },
              {
                "id": 140671540,
                "url": "https://finnhub.io/api/news?id=b85f73c9839ef1c88922e1e344a59e1c8b958316f1c6760961e5524a9583e6e1",
                "image": "https://image.cnbcfm.com/api/v1/image/108323633-5ED3-MM-E-BLOCK-061726.jpg?v=1781738910&w=1920&h=1080",
                "source": "CNBC",
                "related": "ZBH",
                "summary": "'Mad Money' host Jim Cramer weighs in on stocks including: Fair Isaac Corporation, Clover Health, Vistra, and Stryker Corporation.",
                "category": "company",
                "datetime": 1781726833,
                "headline": "Lightning Round: I like FICO but I am afraid it's going to be hurt by AI, says Jim Cramer"
              },
              {
                "id": 140643627,
                "url": "https://finnhub.io/api/news?id=1cf6cf264296e34cf6aa6b883260c6b94b4448c6df4d5586d01127206df8dadb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2210914563/image_2210914563.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZBH",
                "summary": "Zimmer Biomet (ZBH) looks undervalued: strong free cash flow, high margins, sales/EPS growth, buybacks and manageable debt. See more details here.",
                "category": "company",
                "datetime": 1781581929,
                "headline": "Zimmer Biomet: Does Slow And Steady Still Win The Race?"
              },
              {
                "id": 140638992,
                "url": "https://finnhub.io/api/news?id=55c6e6735b3614e92e560eaa15ab79337321693464dc85a5555a3aab2a2c0302",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer Biomet has lagged the broader S&P 500 Index over the past year, and analysts remain on the sidelines as they weigh the company's steady fundamentals against its modest growth outlook.",
                "category": "company",
                "datetime": 1781524151,
                "headline": "Is Zimmer Biomet Stock Underperforming the S&P 500?"
              },
              {
                "id": 140613133,
                "url": "https://finnhub.io/api/news?id=fa7dc8445299911bf16502caaeab45d89c5c4cbbc69b958e2ee1a72a63a007d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Is SOLV a good stock to buy? We came across a bullish thesis on Solventum Corporation on r/ValueInvesting by raytoei. In this article, we will summarize the bulls’ thesis on SOLV. Solventum Corporation’s share was trading at $82.46 as of June 9th. SOLV’s trailing and forward P/E were 10.09 and 12.58 respectively according to Yahoo Finance. Solventum […]",
                "category": "company",
                "datetime": 1781208796,
                "headline": "Is Solventum Corporation (SOLV) A Good Stock To Buy Now?"
              },
              {
                "id": 140602225,
                "url": "https://finnhub.io/api/news?id=9fe49e482bc56bb05f6d592cd872efd951762204c6033e9b9fab15984cbee012",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings currently sits with no changes to its published price targets, so you are working with the same reference points that were already in place. With no fresh analyst commentary on record, recent market moves are not being framed by new Wall Street narratives. Read on to see how you can track future revisions and keep up with how the story around this stock evolves over time. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to...",
                "category": "company",
                "datetime": 1781137165,
                "headline": "Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst Updates"
              },
              {
                "id": 140581614,
                "url": "https://finnhub.io/api/news?id=e807ea147c809c9a05caecce5563b33b2635da17565f7f169c1e40b8dcce745a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Is ZBH a good stock to buy? We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.’s share was trading at $87.27 as of June 8th. ZBH’s trailing and forward P/E were 22.62 and 10.46 respectively according […]",
                "category": "company",
                "datetime": 1781015440,
                "headline": "Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?"
              },
              {
                "id": 140581511,
                "url": "https://finnhub.io/api/news?id=46db3f2ddb8f68a9fda811f499351527e0ebbe2252337876f92aa9582fde5c35",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "ISRG lifts margins despite tariffs, using scale, cost cuts and da Vinci 5 adoption to offset inflation as 2026 cost pressures build.",
                "category": "company",
                "datetime": 1781014020,
                "headline": "Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?"
              },
              {
                "id": 140581528,
                "url": "https://finnhub.io/api/news?id=fff801fa2f8f5420353b512baf5d61c8d4ac7e0cb77437df58f4af361c100815",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Globus Medical is riding on musculoskeletal market growth with strong Q1 sales gains, double-digit spine growth, and rising trauma demand across key product lines.",
                "category": "company",
                "datetime": 1781013660,
                "headline": "Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom"
              },
              {
                "id": 140573692,
                "url": "https://finnhub.io/api/news?id=3c731df515e487f63c0aeca355fc5c45231f7a5fdfaa49df13f31c359af95d84",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings, Inc. (ZBH) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 10:40 AM EDTCompany ParticipantsIvan Tornos -...",
                "category": "company",
                "datetime": 1780938510,
                "headline": "Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"
              },
              {
                "id": 140538765,
                "url": "https://finnhub.io/api/news?id=154616564cbf3982765e3e6bd14f79360db48ccb79cfcda02804e9f0b4f1bb48",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1780673427,
                "headline": "Why Is Perrigo (PRGO) Down 9% Since Last Earnings Report?"
              },
              {
                "id": 140525761,
                "url": "https://finnhub.io/api/news?id=208a7fca9c2fb19fe671ca5b45ad12cb4688fe71c05248efbdeab44509fdb3a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Globus Medical's debt-free balance sheet, nearly $630M in liquid assets and strong cash flow give it the flexibility to fund growth and support shareholders.",
                "category": "company",
                "datetime": 1780588500,
                "headline": "Here's How Financial Strength Remains a Key Advantage for GMED"
              },
              {
                "id": 140500624,
                "url": "https://finnhub.io/api/news?id=a5e65034a45c9049f09c1511bc42d5210be3019312b0c99d59a2ee7bb47837e4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Globus Medical is riding musculoskeletal market growth with spine, trauma and ortho gains, strong cash flow and a debt-free balance sheet.",
                "category": "company",
                "datetime": 1780410540,
                "headline": "Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?"
              },
              {
                "id": 140498523,
                "url": "https://finnhub.io/api/news?id=dc236427ceaf3d1a5e737ff55f7ddacae7bc6aff8b01ca6eaba9f9f8db94bfe7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8 with a fireside chat at 10:40 a.m. ET.",
                "category": "company",
                "datetime": 1780399800,
                "headline": "Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference"
              },
              {
                "id": 140497868,
                "url": "https://finnhub.io/api/news?id=1e939934e2e5739e9e6c8226ea4e4c29629eca8fb63f3fdd9c03c88d0f1eec9e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.",
                "category": "company",
                "datetime": 1780394243,
                "headline": "2 Profitable Stocks to Consider Right Now and 1 We Question"
              },
              {
                "id": 140460516,
                "url": "https://finnhub.io/api/news?id=8087e2bad148885b17ab7dc0369a07e9077ba8fa101ee49c0398193adc357cd4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "GE HealthCare (GEHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1780068606,
                "headline": "GE HealthCare (GEHC) Up 3.3% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 140451402,
                "url": "https://finnhub.io/api/news?id=4d4b45bd859b29d0ba102e343cd5e3952515a884bb0f1e3a10f69952228c51fc",
                "image": "",
                "source": "Benzinga",
                "related": "ZBH",
                "summary": "Citigroup  analyst Joanne Wuensch   maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and lowers the price target from $95 to $93.",
                "category": "company",
                "datetime": 1779984634,
                "headline": "Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $93"
              },
              {
                "id": 140447049,
                "url": "https://finnhub.io/api/news?id=68e783a1f7d7f1c5f76f949885719c7d67d503b03ffbb9896ce38fb811ebf383",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1779982221,
                "headline": "Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 140443709,
                "url": "https://finnhub.io/api/news?id=537fbfb375ad4f7d8910fee5a75b0417b01bb38fbd04ce57abd40c92ecf5833b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destocking have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 1.2% has lagged the S&P 500’s 9.8% climb.",
                "category": "company",
                "datetime": 1779974307,
                "headline": "3 Healthcare Stocks That Fall Short"
              },
              {
                "id": 140435000,
                "url": "https://finnhub.io/api/news?id=acc8a51efa459f1e33a2c33e16a16fb62d5c2d9bd360fe0b82bfab958ec4a472",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announces that its TMINI® Miniature Robotic System has been used in its 5,000th total knee (TKA) procedure. The 5,000th case was recently completed by Dr. John Tiberi of Cedars-Sinai Orthopedics in Los Angeles, CA.",
                "category": "company",
                "datetime": 1779897600,
                "headline": "THINK Surgical Announces the TMINI® Miniature Robotic System 5,000th Procedure Milestone"
              },
              {
                "id": 140435001,
                "url": "https://finnhub.io/api/news?id=8da8881f1410a134869809e6e5294d0385017ddf3b1d73f443ab41aecd5fc04d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Over the past six months, Zimmer Biomet’s shares (currently trading at $85.45) have posted a disappointing 12.4% loss, well below the S&P 500’s 9.1% gain. This might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1779897204,
                "headline": "3 Reasons to Sell ZBH and 1 Stock to Buy Instead"
              },
              {
                "id": 140420479,
                "url": "https://finnhub.io/api/news?id=b70082c170e45eb4b50cc25e05c10dae5407ada933d6c97f101e23b60dd0374d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to $83 from $93 on April 29, and maintained a Buy rating on the shares. The firm stated that the company delivered a solid fiscal Q1 to start the year, […]",
                "category": "company",
                "datetime": 1779797341,
                "headline": "Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 7,
            "negative_hits": 2,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0,
            "source_article_count": 23,
            "discarded_article_count": 16
          },
          "sentimentPoints": 2
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 21.8,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 3.2,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": true,
            "vcp_score": 3.2,
            "vcp_reason": "波幅收縮(12.6%→5%);跌縮量(近10日3日);站上MA50;升放量(近10日2日);收盤突破20日高位;Ready=Y;Confirm=Y",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 2264506.6666666665,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 2302850,
              "avg_vol_20": 2239215,
              "avg_vol_30": 2264506.6666666665,
              "range_pct_10": 0.04958036660777385,
              "range_pct_20": 0.09849823321554772,
              "range_pct_30": 0.12566254416961126,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": true,
              "vol_ratio_10_30": 1.0169323119678753,
              "dist_to_20d_high": -0.0006629834254143897,
              "down_shrink_days": 3,
              "breakout_level_20d": 90.5,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.39455166959578225
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 3.2,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.4388250883392226,
              "turnoverUsdM": 185.50645472,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.6,
          "stopLevels": {
            "symbol": "US.ZBH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 86.1428,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.5,
            "stop_loss_percent": 4.9,
            "take_profit_price": 97.2005,
            "target_multiplier": 2.2,
            "technical_strength": 2.05,
            "take_profit_percent": 7.3
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.4966222946663044,
          "stopLossPercent": 4.877650176678445,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 2.2086,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.44
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "強勢區",
      "score": 10,
      "value": 99.05
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0459
    },
    "kdj": {
      "d": 53.64,
      "j": 72.74,
      "k": 60.01,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "強資金流入",
      "score": 10,
      "value": 73.78
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": 12774337,
      "recentSlope": 501783.7,
      "previousSlope": 776850
    },
    "rsi": 66.03,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 86.8267,
      "position": "SAR喺價下",
      "distancePct": 4.12,
      "previousTrend": "上升"
    },
    "ma50": 86.723,
    "macd": {
      "macd": 0.8605442462234691,
      "trend": "強烈看漲",
      "signal": 0.5971726269544396,
      "histogram": 0.2633716192690295
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 86.5344,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 16
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.92,
      "score": 4,
      "avgVolume": 2238002,
      "currentVolume": 2048437
    },
    "derived": {
      "ma20": 86.606,
      "ma50": 86.723,
      "prevClose": 87.57,
      "avgVolume10": 2320714,
      "avgVolume20": 2238002,
      "changePercent": 3.41,
      "avgVolumeForScore": 2238002
    },
    "ma_cross": {
      "ma20": 86.606,
      "ma50": 86.723,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 86.2985,
      "prevMa50": 86.8186,
      "spreadPct": 0.13,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 81.7264,
      "upper": 91.4856,
      "position": "上半部"
    },
    "rsi_short": 63.69,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.92
    }
  }
}

Raw metrics JSON

{
  "close": 90.56,
  "volume": 2048437,
  "changePercent": 3.41
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.